UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000060120 |
|---|---|
| Receipt number | R000068759 |
| Scientific Title | The effectiveness of 19G FNA and 22G FNB needle for diagnosing lymphadenopathy |
| Date of disclosure of the study information | 2026/01/01 |
| Last modified on | 2025/12/18 12:26:24 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The effectiveness of 19G FNA and 22G FNB needle for diagnosing lymphadenopathy
Acronym
The effectiveness of 19G FNA and 22G FNB needle for diagnosing lymphadenopathy
Scientific Title
The effectiveness of 19G FNA and 22G FNB needle for diagnosing lymphadenopathy
Scientific Title:Acronym
The effectiveness of 19G FNA and 22G FNB needle for diagnosing lymphadenopathy
Region
| Japan |
Condition
Condition
mediastinal or abdominal lymphadenopathy
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To clarify the usefulness of 19G FNA and 22G FNB needles for lymphadenopathy diagnosis
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Diagnostic accuracy of each puncture needle for lymphadenopathy
Key secondary outcomes
Diagnostic sensitivity of malignant lymphoma for each needle
(including 7AAD analysis and G-Band)
Adverse events
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 120 | years-old | >= |
Gender
Female
Key inclusion criteria
>17-years-old
EUS-FNA performed cases with mediastinal or abdominal lymphadenopathy using 19G FNA or 22G FNB needle
Key exclusion criteria
Use of needles other than the 19-gauge FNA needle or 22-gauge FNB needle
inability to provide informed consent
The patients who are otherwise judged by the investigator to be ineligible to participate in the study.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Mitsuru |
| Middle name | |
| Last name | Okuno |
Organization
Matsunami General Hospital
Division name
Gastroenterology
Zip code
501-6062
Address
Dendai 185-1, Kasamatsu-cho, Hashima-gun, GIFU prefecture
TEL
0583880111
mkobdkl@yahoo.co.jp
Public contact
Name of contact person
| 1st name | Mitsuru |
| Middle name | |
| Last name | Okuno |
Organization
Matsunami General Hospital
Division name
Gastroenterology
Zip code
501-6062
Address
Dendai 185-1, Kasamatsu-cho, Hashima-gun, GIFU prefecture
TEL
0583880111
Homepage URL
mkobdkl@yahoo.co.jp
Sponsor or person
Institute
other
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Matsunami General Hospital
Address
Dendai 185-1, Kasamatsu-cho, Hashima-gun, GIFU prefecture
Tel
0583880111
mkobdkl@yahoo.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 01 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 10 | Month | 17 | Day |
Date of IRB
| 2022 | Year | 03 | Month | 01 | Day |
Anticipated trial start date
| 2025 | Year | 11 | Month | 16 | Day |
Last follow-up date
| 2027 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
none
Management information
Registered date
| 2025 | Year | 12 | Month | 18 | Day |
Last modified on
| 2025 | Year | 12 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068759
